Genomic Solutions to Buy GeneMachines for $8.3M
Genomic Solutions said earlier this week it will acquire genomic-tool company GeneMachines for around $8.3 million in cash.
The acquisition is expected to close in mid-March and is subject to the approval of GeneMachines’ shareholders. According to Genomic Solutions’ parent Harvard Bioscience, enough GeneMachines shareholders have already agreed to vote for the acquisition.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.